Apolipoprotein A-I inhibits the production of interleukin-1β and tumor necrosis factor-α by blocking contact-mediated activation of monocytes by T lymphocytes

Blood

Volumn 97, Issue 8, 2001, Pages 2381-2389

  Hyka, N ^a   Dayer, J M ^a   Modoux, C ^a   Kohno, T ^a   Edwards III, C K ^a   Roux Lombard, P ^a   Burger, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; APOLIPOPROTEIN A1; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROSCLEROSIS; CELL ACTIVATION; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; ELECTROPHORESIS; HUMAN; HUMAN CELL; INFLAMMATION; MONOCYTE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION;

EID: 0035871793     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.8.2381     Document Type: Article

References (63)

1. 3 induce on THP-1 cells distinct patterns of cell surface antigen expression, cytokine production, and responsiveness to contact with activated T cells
2. Interactions between T cell plasma membranes and monocytes
3. Cell contact-mediated signaling of monocytes by stimulated T cells: A major pathway for cytokine induction
4. Cell surface glycoproteins expressed on activated human T-cells induce production of interleukin-1 beta by monocytic cells: A possible role of CD69
5. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression
6. Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones
7. Immobilized anti-CD3 antibody activates T cell clones to induce the production of interstitial collagenase, but not tissue inhibitor of metalloproteinases, in monocytic THP-1 cells and dermal fibroblasts
8. Human Th1 cells preferentially induce interleukin (IL)-1 beta while Th2 cells induce IL-1 receptor antagonist production upon cell/cell contact with monocytes
9. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis
10. The vitronectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23
11. Role of the CD40-CD40 ligand interaction in CD4(+) T cell contact-dependent activation of monocyte interleukin-1 synthesis
12. Lymphocyte activation gene-3, a MHC class II ligand expressed on activated T cells, stimulates TNF-alpha and IL-alpha production by monocytes and dendritic cells
13. Soluble CD23 directly activates monocytes to contribute to the antigen-independent stimulation of resting T cells
14. Engagement of CD11b and CD11c beta2 integrin by antibodies or soluble CD23 induces IL-1 beta production on primary human monocytes through mitogen-activated protein kinase-dependent pathways
15. Imbalance between interstitial collagenase (MMP-1) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: Involvement of membrane-associated cytokines
16. Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells
17. Disease-specific ex vivo stimulation of whole blood for cytokine production: Applications in the study of tuberculosis
18. Cytokine production (IL-6 and TNF-alpha) in whole blood cell cultures of patients with systemic lupus erythematosus
19. Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis
20. Acute-phase proteins and other systemic responses to inflammation
21. Mitogen requirements for the in vitro propagation of T-cell lymphomas
22. Establishment and characterization of a human acute monocyte leukemia cell line (THP-1)
23. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum
24. The identification of specific high-density lipoprotein 3 binding sites on human blood monocytes using fluorescence-labeled ligand
25. Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases
26. Delipidation of plasma lipoproteins
27. The epitope(s) recognized by HNK-1 antibody and IgM paraprotein in neuropathy is present on several N-linked oligosaccharide structures on human P0 and myelin-associated glycoprotein
28. Plasma apolipoprotein A and B concentrations in growth-retarded fetuses: A link between low birth weight and adult atherosclerosis
29. Cytokines and growth factors
30. Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other diseases
31. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
32. Immunological treatment of autoimmune diseases
33. Biologic agents for treating rheumatoid arthritis. Concepts and progress
34. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
35. Anti-TNF antibody treatment of Crohn's disease
36. Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia
37. Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein
38. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes
39. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria
40. Structural determinants for the interaction of lipopolysaccharide binding protein with purified high-density lipoproteins: Role of apolipoprotein A-I
41. Promotion of lymphocyte growth by high-density lipoproteins (HDL). Physiological significance of the HDL binding site
42. Molecular mechanisms of reverse cholesterol transport
43. The differential miscibility of lipids as the basis for the formation of functional membrane rafts
44. In vitro reverse cholesterol transport from THP-1-derived macrophage-like cells with synthetic HDL particles consisting of proapolipoprotein A1 or apolipoprotein A1 and phosphatidylcholine
45. High-density lipoprotein receptors, binding proteins, and ligands
46. Charting the fate of the "good cholesterol": Identification and characterization of the high-density lipoprotein receptor SR-BI
47. 12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein
48. Low levels of total cholesterol, high-density lipoprotein, and apolipoprotein AI in association with anticardiolopin antibodies in patients with SLE
49. Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE
50. Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity
51. Lipid profiles in untreated patients with rheumatoid arthritis
52. Analysis of changes in acute-phase plasma proteins in an acute inflammatory response and in rheumatoid arthritis using two-dimensional gel electrophoresis
53. Serum total, HDL, LDL cholesterol, and triglyceride levels in patients with rheumatoid arthritis
54. Apolipoproteins A-I and B and cholesterol in synovial fluid of patients with rheumatoid arthritis
55. Serum amyloid A, the major vertebrate acute-phase reactant
56. Local expression of acute phase serum amyloid A mRNA in rheumatoid arthritis synovial tissue and cells
57. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition
58. Human serum amyloid A has cytokine-like properties
59. Atherosclerosis - An inflammatory disease
60. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association
61. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice
62. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
63. Inflammation-mediated rheumatic diseases and atherosclerosis